Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 737.00
Bid: 738.00
Ask: 743.00
Change: -12.00 (-1.60%)
Spread: 5.00 (0.678%)
Open: 718.00
High: 750.00
Low: 718.00
Prev. Close: 749.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of acquisition and Total Voting Rights

17 Jul 2014 11:17

RNS Number : 6099M
Acal PLC
17 July 2014
 



17 July 2014

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Acal plc

Completion of acquisition and Total Voting Rights

 

Acal plc (LSE: ACL, the "Company" or "Acal"), a leading specialist electronics supplier, is pleased to announce that all outstanding conditions have now been satisfied and the acquisition of Trafo Holding AS, trading as Noratel, has completed today.

 

Further to the completion of the Acquisition, application has been made for 384,966 new ordinary shares of 5 pence each, issued pursuant to the Sale and Purchase Agreement (the "Consideration Shares") to be admitted to the Official List of the UKLA and to trading on the London Stock Exchange's main market for listed securities ("Admission"). It is expected that Admission will occur on 18 July 2014. For the number of issued shares admitted to the Official List to equal the Company's number of issued ordinary shares, application is also being made for a further 290,873 ordinary shares (which have already been issued) to be so admitted.

 

Immediately following the issue of these new ordinary shares, the issued share capital of the Company comprises 63,049,220 ordinary shares of 5 pence each. All of the ordinary shares carry voting rights of one vote per share. The Company does not hold any shares in treasury. The above figure of 63, 049,220 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

 

A prospectus and circular relating to the Consideration Shares and the Acquisition was published on 5 June 2014 and submitted to the National Storage Mechanism where it is available for inspection at www.morningstar.co.uk/uk/NSM.

 

For further information, please contact:

 

Acal plc

01483 544 500

Nick Jefferies

Simon Gibbins

 

Sponsor, sole bookrunner and broker

Oriel Securities

0207 710 7600

David Arch

Ashton Clanfield

Stewart Wallace

Instinctif Partners

0207 457 2020

Mark Garraway

Helen Tarbet

 

 

Notes to Editors:

 

About Acal plc

 

Acal is a European leader in specialist electronics, designing, manufacturing and distributing electronic, photonic and medical products for the industrial and healthcare sectors. It is the only such provider with an infrastructure to deliver a broad range of specialist products and bespoke solutions across Europe. The Electronics division has completed seven acquisitions in the last four years, more than trebling its specialist revenues. Acal's strategy is to further enhance its leadership position through organic growth, complementary acquisitions and continued enhancement of its custom service capabilities. The division has operating companies across Europe, including the UK, Germany, France, Benelux, Italy, Poland, Spain and the Nordic region, as well as in Asia (China and South Korea) and Africa (South Africa). Businesses comprise Acal BFi, Hectronic, MTC, Myrra Group, RSG, Stortech and Vertec.

 

IMPORTANT NOTICE

The defined terms set out in Part XVIII of the Prospectus apply in this announcement.

A copy of the Prospectus is available from the registered office of the Company and on the Company's website at www.acalplc.co.uk provided that the Prospectus will not, subject to certain exceptions, be available (whether through the website or otherwise) to Shareholders in the United States or any of the other Excluded Territories.

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement. The Prospectus gives further details of the Rights Issue Shares, the Nil Paid Rights and the Fully Paid Rights being offered pursuant to the Rights Issue.

This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, Nil Paid Rights, Fully Paid Rights or Rights Issue Shares or to take up any entitlements to Nil Paid Rights in any jurisdiction in which such an offer or solicitation is unlawful. The information contained in this announcement is not for release, publication or distribution to persons in the United States or any of the other Excluded Territories and should not be distributed, forwarded to or transmitted in or into any jurisdiction where to do so might constitute a violation of local securities laws or regulations.

The Provisional Allotment Letters, the Nil Paid Rights, the Fully Paid Rights and the Rights Issue Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or under any securities laws of any state or other jurisdiction of the United States, and may not be offered, sold, taken up, exercised, resold, renounced, or otherwise transferred, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States.

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGMNGNVGDZM
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
28th Mar 20247:30 amRNSDirector Declaration
22nd Mar 20248:09 amRNSNotification of Major Holdings
20th Mar 20243:45 pmRNSDirector/PDMR Shareholding
14th Mar 20241:21 pmRNSDirector/PDMR Shareholding
19th Feb 20244:07 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSTrading Update
29th Jan 202410:31 amRNSDirector / PDMR Shareholding
8th Jan 20248:41 amRNSNotification of Major Holdings
4th Jan 20244:03 pmRNSNotification of Major Holdings
21st Dec 20233:57 pmRNSNotification of Major Holdings
13th Dec 20239:03 amRNSNotification of Major Holdings
8th Dec 202310:52 amRNSNotification of Major Holdings
5th Dec 20237:00 amRNSInterim Results
22nd Nov 20238:30 amRNSNotice of Interim Results
11th Oct 20237:00 amRNSFirst Half Trading Update
15th Sep 20239:11 amRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSAcquisition of 2J Antennas Group
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.